Alcon SmartCataract study shows enhanced time savings during cataract surgery

Alcon (NYSE:ALC) announced data from a clinical study supporting the use of its SmartCataract solutions for cataract surgery.

Related Keywords

Geneva ,Genè ,Switzerland ,United States ,Utah ,American ,Zachary Zavodni ,American Society Of Cataract ,Eye Institute ,Surgical Digital Health Solutions Brian Oneal ,Switzerland Based Alcon ,American Society ,Refractive Surgery ,Optiwave Refractive Analysis ,Medical Director ,Surgical Digital Health Solutions Briano Neal ,